FDA Votes in Favor of Benefit-Risk Profile for Moderna’s Flu Vaccine
Moderna said the FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously that the benefits of the vaccine, mRNA-1010, exceed the risks for the prevention of flu in adults 50 through 64 years old, and in adults 65 years of age and older.
The Source
TWSJ
Business
U.K. Consumer Confidence Remains Close to Multiyear Lows
TWSJ·1h ago·3 min read
World News
Crazy Rich Returns Lure Cabbies and Even Kids to Red-Hot Asian Markets
TWSJ·25m ago·3 min read
Business
Japan’s Consumer Inflation Held Steady in May
TWSJ·1h ago·3 min read
Tech
Why Apple’s War Chest Can’t Win the Memory War
TWSJ·1h ago·3 min read
Related
On this beat
Health
How To Prioritise Your Recovery Even When Life Gets Stressful
AOHL·7h ago·3 min read
Health
Many World Cup Fans Would Rather Skip the Hydration Breaks
TNYT·9h ago·3 min read
Health
Best Vivity Lens Cataract Surgeon In Estero: Top IOL Specialist Guide
AOHL·9h ago·3 min read
Health
Utah is testing out AI doctors for prescription refills and actual doctors aren’t happy about it
TWSJ·10h ago·3 min read